These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 20961694)

  • 1. Inflammaging: the driving force in osteoporosis?
    Lencel P; Magne D
    Med Hypotheses; 2011 Mar; 76(3):317-21. PubMed ID: 20961694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone histomorphometry in the pathophysiological evaluation of primary and secondary osteoporosis and various treatment modalities.
    Steiniche T
    APMIS Suppl; 1995; 51():1-44. PubMed ID: 7669370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the complex relations between inflammation and aging (inflamm-aging): anti-inflamm-aging remodelling of inflamm- aging, from robustness to frailty.
    Giunta S
    Inflamm Res; 2008 Dec; 57(12):558-63. PubMed ID: 19109735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A unitary model for involutional osteoporosis: estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in aging men.
    Riggs BL; Khosla S; Melton LJ
    J Bone Miner Res; 1998 May; 13(5):763-73. PubMed ID: 9610739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis.
    Pacifici R
    J Bone Miner Res; 1996 Aug; 11(8):1043-51. PubMed ID: 8854239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Age-related and menopause-related changes of urinary excretion of C- and N-terminal cross-linked telopeptides of type I collagen and the relationships thereof with menopause-related bone loss].
    Liu SP; Liao EY; Wu XP; Cao XZ; Shan PF; Su X
    Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(6):371-5. PubMed ID: 16677543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis.
    Garnero P; Sornay-Rendu E; Chapuy MC; Delmas PD
    J Bone Miner Res; 1996 Mar; 11(3):337-49. PubMed ID: 8852944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary hydroxypyridinium crosslinks of collagen as markers of bone resorption and estrogen efficacy in postmenopausal osteoporosis.
    Seibel MJ; Cosman F; Shen V; Gordon S; Dempster DW; Ratcliffe A; Lindsay R
    J Bone Miner Res; 1993 Jul; 8(7):881-9. PubMed ID: 8352070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteoporosis.
    Gillespy T; Gillespy MP
    Radiol Clin North Am; 1991 Jan; 29(1):77-84. PubMed ID: 1985330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Biochemical markers of bone turnover : clinical usefulness in osteoporosis].
    Garnero P; Delmas PD
    Ann Biol Clin (Paris); 1999; 57(2):137-48. PubMed ID: 10210740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans.
    Franceschi C; Capri M; Monti D; Giunta S; Olivieri F; Sevini F; Panourgia MP; Invidia L; Celani L; Scurti M; Cevenini E; Castellani GC; Salvioli S
    Mech Ageing Dev; 2007 Jan; 128(1):92-105. PubMed ID: 17116321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced bone formation and increased bone resorption: rational targets for the treatment of osteoporosis.
    Seeman E
    Osteoporos Int; 2003; 14 Suppl 3():S2-8. PubMed ID: 12730770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapeutic concepts in the treatment of postmenopausal osteoporosis].
    Leidig-Bruckner G; Ziegler R
    Ther Umsch; 1994 Nov; 51(11):737-47. PubMed ID: 7839332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of early age at menopause on vertebral bone mass.
    Pouillès JM; Trémollières F; Bonneu M; Ribot C
    J Bone Miner Res; 1994 Mar; 9(3):311-5. PubMed ID: 8191923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. American College of Sports Medicine position stand. Osteoporosis and exercise.
    Med Sci Sports Exerc; 1995 Apr; 27(4):i-vii. PubMed ID: 7791573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic features of menopausal and postmenopausal applicants for life insurance.
    Schiefeling M
    J Insur Med; 1996; 28(1):27-34. PubMed ID: 10172866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Normal bone remodelling--what can go wrong in osteoporosis?].
    Midtby M; Magnus JH
    Tidsskr Nor Laegeforen; 1998 Feb; 118(4):552-7. PubMed ID: 9520583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone remodeling increases substantially in the years after menopause and remains increased in older osteoporosis patients.
    Recker R; Lappe J; Davies KM; Heaney R
    J Bone Miner Res; 2004 Oct; 19(10):1628-33. PubMed ID: 15355557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DHEA, important source of sex steroids in men and even more in women.
    Labrie F
    Prog Brain Res; 2010; 182():97-148. PubMed ID: 20541662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.